Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-15

FDA Approved: LEVETIRACETAM — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original application for levetiracetam as a generic drug (Novadoz Pharmaceuticals LLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)